Monitoring immune function during tacrolimus tapering in small bowel transplant recipients
- 31 October 2005
- journal article
- research article
- Published by Elsevier in Transplant Immunology
- Vol. 15 (1) , 17-24
- https://doi.org/10.1016/j.trim.2005.03.019
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Tolerogenic immunosuppression for organ transplantationThe Lancet, 2003
- Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient managementClinical Transplantation, 2003
- CD8+CD28− T suppressor cells and the induction of antigen‐specific, antigen‐presenting cell‐mediated suppression of Th reactivityImmunological Reviews, 2001
- Quantitation of Immunosuppression by Tacrolimus Using Flow Cytometric Analysis of Interleukin-2 and Interferon-γ Inhibition in CD8− and CD8+ Peripheral Blood T CellsTherapeutic Drug Monitoring, 2001
- Clinical Utility of Monitoring Tacrolimus Blood Concentrations in Liver Transplant PatientsThe Journal of Clinical Pharmacology, 2001
- Bioenergetics of immune functions: fundamental and therapeutic aspectsImmunology Today, 2000
- Clinical Intestinal Transplantation: New Perspectives and Immunologic Considerations 1 1This study was supported in part by Project Grant No. DK 29661 from the National Institutes of Health, Bethesda, MD.Journal of the American College of Surgeons, 1998